Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Research indicates that discontinuing GLP-1 medications after achieving weight loss goals often leads to weight regain
Plain Language Summary Obesity is a growing public health issue that increases the risk of developing heart disease, type 2 diabetes, and osteoarthritis
Personalized Care Every body is unique
Understanding Semaglutide and Its Benefits Semaglutide is an FDA-approved GLP-1 receptor agonist, used primarily for long-term weight management in individuals with obesity or who are overweight and have at least one other weight-related condition
Studies consistently show significant weight regain when GLP-1 medications are stopped, and staying on them indefinitely (which was already expensive) is now a legal question, not just a financial one
Warehouses Tirzepatide (GLP2-T), also designated LY3298176, is a synthetic dual-receptor agonist peptide supplied by Nextday Peptides for laboratory and analytical research applications
US$ 22.21
US$ 25.00
US$ 29.63
US$ 28.87
US$ 28.96
US$ 20.08
